[.
]Action/Kinetics:
Duration: 6 hr. Metabolized in the liver and excreted through the urine.
Uses:
Adjunct in peptic ulcer therapy. Spastic and inflammatory disease of GI and urinary tracts. Control of salivation and enuresis. Duodenography. Second-line therapy for urinary incontinence.
Special Concerns:
Safety and effectiveness for use in children with peptic ulcer have not been established.
How Supplied:
Tablet: 7.5 mg, 15 mg
Dosage
•Tablets
GI problems.
Adults: 15 mg 30 min before meals and 30 mg at bedtime. Reduce dose to 7.5 mg t.i.d. for mild symptoms, geriatric clients, or clients of small stature. Pediatric: 0.375 mg/kg (10 mg/m2) q.i.d. with dose being adjusted as needed.
Urinary incontinence.
Adults: 7.5-30 mg 3-5 times/day; in some, doses as high as 15-60 mg q.i.d. may be needed.
Discuss prescriptions and health topics in the new 
